JAMIL KHURRAM (Chief Medical Officer) sold 16.25K shares of GALECTIN THERAPEUTICS INC on the open market
Open‑market sale worth $83.3K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/16/2026ACC: 0001133416-26-000063
Officer· Chief Medical Officer
Since Aug 2024
-16.25K
Net shares
Net seller
$83.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
16.25K acquired · 32.50K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+16.25K
Price / share
$3.04
Trade value
$49.40K
% of position
New position
7/14/2026
0.00→16.25K
Common Stock
Direct
Shares
−16.25K
Price / share
$5.13
Trade value
$83.28K
% of position
New position
7/14/2026
16.25K→0.00
Total
Net shares
+0.00
Net value
-$33.88K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/14/2026 | M · Option Exercise | +16.25K | $3.04 | $49.40K | New position | 0.00 | 16.25K |
| Common Stock Direct | 7/14/2026 | S · Sale | −16.25K | $5.13 | $83.28K | New position | 16.25K | 0.00 |
| Total | +0.00 | -$33.88K | ||||||
Derivative Transactions1
Stock option (right to buy)
Direct
Converts to
Common Stock
16.25K shares
Shares
−16.25K
Strike price
3.04
Held after
48.75K
Exercisable
—
7/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock option (right to buy) Direct | Common Stock16.25K shares | 7/14/2026 | M · Option Exercise | −16.25K | 3.04 | — | 48.75K |